Neridronate (Standard)

Neridronate (Standard) is the analytical standard of Neridronate. This product is intended for research and analytical applications. Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB) . Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases[1][2].

Product Specifications

CAS Number

[79778-41-9]

UNSPSC

12352100

Target

Others; Reference Standards

Related Pathways

Others

Field of Research

Cancer

Smiles

OC(P(O)(O)=O)(CCCCCN)P(O)(O)=O

Molecular Formula

C6H17NO7P2

Molecular Weight

277.15

References & Citations

[1]Gatti D, et al. Clinical development of neridronate: potential for new applications. Ther Clin Risk Manag. 2013;9:139-47.|[2]Guiducci L, et al. Monthly Intramuscular Neridronate for the Treatment of Postmenopausal Osteoporosis: Results of a 6-Year Prospective Italian Study. Int J Endocrinol. 2019 Feb 6;2019:9802827.